ArticlePloS one2014

Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus.

Tadeusz Kolodka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.